TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Characterize IMISC Treatment Regimens in Clinical Practice
Timeframe: 25 Years
Evaluate Patient Outcomes in Clinical Practice
Timeframe: 25 Years
Evaluate Adverse Events of IMISC and treatment in Clinical Practice
Timeframe: 25 Years